September 30, 2026 - 21:59

Micron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker reported quarterly earnings and revenue that cleared elevated targets, signaling robust demand across its key markets. Following the announcement, shares of Micron moved higher in trading.
The company's performance was driven by sustained momentum in memory and storage solutions, particularly as demand for artificial intelligence infrastructure continues to reshape the semiconductor landscape. High-bandwidth memory products have become a critical component for AI accelerators, and Micron has positioned itself as a key supplier in that space. The quarter's results suggest the company is capitalizing on these trends more effectively than some analysts had anticipated.
Beyond the quarterly beat, Micron also issued guidance that topped consensus estimates. The forward outlook points to continued strength in the periods ahead, reinforcing confidence that the current upcycle in memory markets has staying power. Management pointed to improving pricing conditions and steady order flow as factors supporting the optimistic forecast.
Investors responded positively to the dual news of the earnings beat and the above-consensus guide. The results place Micron among the semiconductor companies benefiting most directly from the AI-driven buildout, and the guidance suggests that momentum is not expected to fade in the near term.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...